Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
FARALLON CAPITAL MANAGEMENT LLC (CIK 909661) reported $21.68B across 83 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: SPY ($4.48B, 20.67%), RVMD ($2.54B, 11.71%), EA ($1.62B, 7.49%), BBIO ($800.1M, 3.69%), PTGX ($778.2M, 3.59%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SPY | STATE STR SPDR S&P 500 ETF T | $4.48B | 20.67% | 6.0M | New |
| 2 | RVMD | REVOLUTION MEDICINES INC | $2.54B | 11.71% | 13.6M | Trimmed |
| 3 | EA | ELECTRONIC ARTS INC | $1.62B | 7.49% | 7.9M | Added |
| 4 | BBIO | BRIDGEBIO PHARMA INC | $800.1M | 3.69% | 10.7M | Added |
| 5 | PTGX | PROTAGONIST THERAPEUTICS INC | $778.2M | 3.59% | 6.3M | Hold |
| 6 | EXEL | EXELIXIS INC | $732.8M | 3.38% | 13.5M | Added |
| 7 | LQDA | LIQUIDIA CORPORATION | $666.9M | 3.08% | 8.4M | Trimmed |
| 8 | AMZN | AMAZON COM INC | $627.5M | 2.90% | 2.6M | Trimmed |
| 9 | LNTH | LANTHEUS HLDGS INC | $619.4M | 2.86% | 5.6M | Hold |
| 10 | NTRA | NATERA INC | $602.2M | 2.78% | 2.2M | Trimmed |
| 11 | UNH | UNITEDHEALTH GROUP INC | $528.1M | 2.44% | 1.3M | Trimmed |
| 12 | TMO | THERMO FISHER SCIENTIFIC INC | $526.0M | 2.43% | 1.0M | Added |
| 13 | ROIV | ROIVANT SCIENCES LTD | $506.4M | 2.34% | 14.3M | Added |
| 14 | AON | AON PLC | $458.6M | 2.12% | 1.4M | Trimmed |
| 15 | BSX | BOSTON SCIENTIFIC CORP | $449.0M | 2.07% | 10.5M | Added |
| 16 | AVGO | BROADCOM INC | $435.1M | 2.01% | 1.2M | Trimmed |
| 17 | MSFT | MICROSOFT CORP | $415.1M | 1.92% | 1.1M | Trimmed |
| 18 | TNGX | TANGO THERAPEUTICS INC | $383.8M | 1.77% | 12.3M | Added |
| 19 | KKR | KKR & CO INC | $378.0M | 1.74% | 4.1M | Trimmed |
| 20 | SNPS | SYNOPSYS INC | $370.1M | 1.71% | 829,600 | Trimmed |
| 21 | BEAM | BEAM THERAPEUTICS INC | $351.3M | 1.62% | 10.2M | Added |
| 22 | CRNX | CRINETICS PHARMACEUTICALS IN | $336.4M | 1.55% | 9.0M | Added |
| 23 | GRAL | GRAIL INC | $284.1M | 1.31% | 4.2M | Added |
| 24 | WAB | WABTEC | $241.2M | 1.11% | 894,503 | Trimmed |
| 25 | IMVT | IMMUNOVANT INC | $223.7M | 1.03% | 5.8M | Added |
Source: SEC Form 13F filings · as of 2026-06-30